Mod­er­na pens deal with Chi­na to make mR­NA med­i­cines that 'will not be ex­port­ed'

Mod­er­na signed a deal Wednes­day to de­vel­op and man­u­fac­ture mR­NA med­i­cines in Chi­na, af­ter oth­er US and Eu­ro­pean Covid-19 drug­mak­ers strug­gled to break in­to the mar­ket with­out a Chi­nese part­ner.

Un­der the agree­ment, the Cam­bridge, MA vac­cine de­vel­op­er will pro­duce med­i­cines in Chi­na that “will be ex­clu­sive­ly for the Chi­nese peo­ple” and “will not be ex­port­ed,” ac­cord­ing to an emailed state­ment from Mod­er­na.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER